Jones Financial Companies Lllp Pmv Pharmaceuticals, Inc. Transaction History
Jones Financial Companies Lllp
- $105 Billion
- Q4 2024
A detailed history of Jones Financial Companies Lllp transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 1,000 shares of PMVP stock, worth $1,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$1,370% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PMVP
# of Institutions
78Shares Held
41.9MCall Options Held
500Put Options Held
500-
Orbimed Advisors LLC San Diego, CA6.48MShares$8.87 Million0.26% of portfolio
-
Sio Capital Management, LLC New York, NY3.57MShares$4.89 Million2.01% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.51MShares$4.81 Million0.08% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.47MShares$4.75 Million3.25% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.6 Million0.54% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $62.5M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...